Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Bronchiolitis Obliterans Syndrome × milatuzumab × Clear all

Sponsor

Conditions

Waldenstrom Macroglobulinemia 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1

Interventions

tofacitinib 7 Rituximab 3 obinutuzumab 2 nilotinib 2 ibrutinib 2 bosutinib 2 Imatinib Mesylate 2 ruxolitinib 1 ofatumumab 1 fludarabine 1 canakinumab 1 belumosudil 1 baricitinib 1 axatilimab 1 Sofosbuvir 1 Ribavirin 1 Lenalidomide 1 KW-2478 1 KD025 1 Interleukin-15 1 Hsp90 inhibitor KU757 1 Etanercept 1 Dasatinib 1 Cyclophosphamide 1 Bortezomib 1 BMS-833923 1 B3(Fv)-PE38KDEL recombinant immunotoxin 1 Alemtuzumab 1 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡